Press Releases Ampio Pharmaceuticals, Inc.

Equities

AMPE

US03209T3077

Delayed OTC Markets Other stock markets 11:48:29 2024-04-30 am EDT			5-day change	1st Jan Change
0.251 ^USD	-33.95%		-12.24%	-87.76%

Apr. 15	Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index	CI
Mar. 27	Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Thinking about buying stock in Fusion Pharmaceuticals, Aptevo Therapeutics, Blink Charging, Ampio Pharmaceuticals, or Bitcoin Depot?	Dec. 28	PR
Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group ?	Nov. 30	PR
AMPIO PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-11-09	AQ
AMPIO PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-10-14	AQ
AMPIO PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	22-10-04	AQ
AMPIO PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-09-01	AQ
Ampio Pharmaceuticals : Submission of Matters to a Vote of Security Holders - Form 8-K	22-08-12	PU
AMPIO PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-08-12	AQ
Ampio Pharmaceuticals : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)	22-08-09	PU
AMPIO PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-09	AQ
Ampio Pharmaceuticals : Letter to Stockholders	22-08-03	PU
Ampio Pharmaceuticals : rsquo; Chairman of the Board Kevin Buchi and CEO Mike Martino Issues Letter to Stockholders - Form 8-K	22-08-03	PU
AMPIO PHARMACEUTICALS, INC. : Costs Associated with Exit or Disposal Activities, Other Events (form 8-K)	22-08-03	AQ
AMPIO PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-06-24	AQ
AMPIO PHARMACEUTICALS CEO MIKE MARTINO ISSUES LETTER TO STOCKHOLDERS	22-06-03	AQ
Ampio Pharmaceuticals : rsquo; CEO Mike Martino Issues Letter to Stockholders - Form 8-K	22-06-02	PU
Ampio Pharmaceuticals : rsquo; CEO Mike Martino Issues Letter to Stockholders	22-06-02	PU
AMPIO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-06-02	AQ
AMPIO PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)	22-06-01	AQ
Ampio: Q1 Earnings Snapshot	22-05-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Ampio Pharmaceuticals, Inc.

Equities

AMPE

US03209T3077

Press Releases

Filters